Pinto L F, Moraes E, Albano R M, Silva M C, Godoy W, Glisovic T, Lang M A
Departamento de Bioquímica, IBRAG, Universidade do Estado do Rio de Janeiro, Av. 28 de Setembro, 87, fundos, 4 degrees andar, Vila Isabel, Rio de Janeiro, RJ, Brasil.
Carcinogenesis. 2001 Nov;22(11):1877-83. doi: 10.1093/carcin/22.11.1877.
N-nitrosodiethylamine (NDEA) is able to induce tumours in the rat oesophagus. It has been suggested that this could be due to tissue specific expression of NDEA activating cytochrome P450 enzymes. We investigated this by characterizing the oesophageal monooxygenase complex of male Wistar rats and comparing it with that of the liver. Total amount of cytochrome P450, NADPH P450 reductase, cytochrome b5 and cytochrome b5 reductase of the oesophageal mucosa was approximately 7% of what was found in the liver. In addition, major differences were found in the cytochrome P450 isoenzyme composition between these organs: CYP 2B1/2B2 and CYP3A were found only in the liver, whereas CYP1A1 was constitutively expressed only in the oesophagus. Of the two well-known nitrosamine metabolizing enzymes, CYP2A3 was found only in the oesophagus whereas CYP2E1 was exclusively expressed in the liver. Catalytic studies, western blotting and RT-PCR analyses confirmed the expression of CYP2A3 in the oesophagus. CYP2A enzymes are known to be good catalysts of NDEA metabolism. Oesophageal microsomes had a K(m) for NDEA metabolism, which was about one-third of that of hepatic microsomes, but they showed similar activities when compared per nmol of total P450. NDEA activity in the oesophagus was significantly increased by coumarin (CO), which also induced oesophageal CYP2A3. Immunoinhibition of the microsomal NDEA activity showed that up to 70% of this reaction is catalysed by CYP2A3 in the oesophagus, whereas no inhibition of the hepatic NDEA activity could be achieved by the anti-CYP2A5 antibody. NDEA, but not N-nitrosodimethylamine (NDMA) inhibited the oesophageal metabolism of CO. The results of the present investigation show major differences in the enzyme composition of the oesophageal and hepatic monooxygenase complexes, and are in accordance with the hypothesis that the NDEA organotropism could, to a large extent, be due to the tissue specific expression of the activating enzymes.
N-亚硝基二乙胺(NDEA)能够诱发大鼠食管肿瘤。有人认为,这可能是由于NDEA激活细胞色素P450酶的组织特异性表达所致。我们通过对雄性Wistar大鼠的食管单加氧酶复合物进行表征并将其与肝脏的进行比较来对此进行研究。食管黏膜中细胞色素P450、NADPH P450还原酶、细胞色素b5和细胞色素b5还原酶的总量约为肝脏中发现量的7%。此外,这些器官之间在细胞色素P450同工酶组成上存在主要差异:CYP 2B1/2B2和CYP3A仅在肝脏中发现,而CYP1A1仅在食管中组成性表达。在两种著名的亚硝胺代谢酶中,CYP2A3仅在食管中发现,而CYP2E1仅在肝脏中特异性表达。催化研究、蛋白质印迹法和逆转录聚合酶链反应分析证实了CYP2A3在食管中的表达。已知CYP2A酶是NDEA代谢的良好催化剂。食管微粒体对NDEA代谢的米氏常数(K(m))约为肝微粒体的三分之一,但每nmol总P450比较时它们显示出相似的活性。香豆素(CO)显著增加了食管中的NDEA活性,香豆素还诱导了食管CYP2A3。对微粒体NDEA活性的免疫抑制表明,该反应高达70%由食管中的CYP2A3催化,而抗CYP2A5抗体无法抑制肝脏中的NDEA活性。NDEA而非N-亚硝基二甲胺(NDMA)抑制了CO的食管代谢。本研究结果表明食管和肝脏单加氧酶复合物的酶组成存在主要差异,并且与以下假设一致,即NDEA的器官嗜性在很大程度上可能归因于激活酶的组织特异性表达。